UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 648

Sortiert nach

Which threshold for ER positivity? a retrospective study based on 9639 patients

Annals of oncology, 2014-05, Vol.25 (5), p.1004-1011

2014

Volltextzugriff (PDF)

Role of biologic therapy and chemotherapy in hormone receptor- and HER2-positive breast cancer

Annals of oncology, 2009-06, Vol.20 (6), p.993-999

Buzdar, A. U

2009

Volltextzugriff (PDF)

Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer

Annals of oncology, 2013-08, Vol.24 (8), p.1999-2004

2013

Volltextzugriff (PDF)

Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer

Journal of clinical oncology, 1996-08, Vol.14 (8), p.2197-2205

1996

Volltextzugriff (PDF)

Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511)

Breast cancer research and treatment, 2017-01, Vol.161 (2), p.363-373

2017

Volltextzugriff (PDF)

Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers

Annals of oncology, 2007-05, Vol.18 (5), p.874-880

2007

Volltextzugriff (PDF)

Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast Cancer

Journal of clinical oncology, 1999-02, Vol.17 (2), p.485-493

1999

Volltextzugriff (PDF)

Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy

Journal of clinical oncology, 1999-02, Vol.17 (2), p.460-469

1999

Volltextzugriff (PDF)

Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer

Annals of oncology, 2012-03, Vol.23 (3), p.589-597

2012

Volltextzugriff (PDF)

Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab

Annals of oncology, 2008-12, Vol.19 (12), p.2020-2025

2008

Volltextzugriff (PDF)

Collagen IV levels are elevated in the serum of patients with primary breast cancer compared to healthy volunteers

British journal of cancer, 2008-07, Vol.99 (1), p.68-71

2008

Volltextzugriff (PDF)

Locoregional Recurrence Patterns After Mastectomy and Doxorubicin-Based Chemotherapy: Implications for Postoperative Irradiation

Journal of clinical oncology, 2000-08, Vol.18 (15), p.2817-2827

2000

Volltextzugriff (PDF)

Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer

Journal of clinical oncology, 1995-12, Vol.13 (12), p.2886-2894

1995

Volltextzugriff (PDF)

Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer

JNCI : Journal of the National Cancer Institute, 1991-12, Vol.83 (24), p.1797-1805

1991

Volltextzugriff (PDF)

Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy—results from the ACOSOG Z1041 (Alliance) trial

Annals of oncology, 2017-05, Vol.28 (5), p.1070-1077

2017

Volltextzugriff (PDF)

Management of Breast Cancer During Pregnancy Using a Standardized Protocol

Journal of clinical oncology, 1999-03, Vol.17 (3), p.855-861

1999

Volltextzugriff (PDF)

Use of tamoxifen for breast cancer: twenty-eight years later

Journal of clinical oncology, 1995-02, Vol.13 (2), p.513-529

1995

Volltextzugriff (PDF)

Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma

Clinical cancer research, 1997-09, Vol.3 (9), p.1565-1569

1997

Volltextzugriff (PDF)

Inflammatory breast carcinoma incidence and survival : The Surveillance, Epidemiology, and end results program of the National Cancer Institute, 1975-1992

Cancer, 1998-06, Vol.82 (12), p.2366-2372

1998

Volltextzugriff (PDF)

Update on endocrine therapy for breast cancer

Clinical cancer research, 1998-03, Vol.4 (3), p.527-534

1998

Volltextzugriff (PDF)

Long-Term Results of Combined-Modality Therapy for Locally Advanced Breast Cancer With Ipsilateral Supraclavicular Metastases: The University of Texas M.D. Anderson Cancer Center Experience

Journal of clinical oncology, 2001-02, Vol.19 (3), p.628-633

2001

Volltextzugriff (PDF)

Prospective Evaluation of Paclitaxel Versus Combination Chemotherapy With Fluorouracil, Doxorubicin, and Cyclophosphamide as Neoadjuvant Therapy in Patients With Operable Breast Cancer

Journal of clinical oncology, 1999-11, Vol.17 (11), p.3412-3417

1999

Volltextzugriff (PDF)

Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast cancer

Journal of clinical oncology, 1996-10, Vol.14 (10), p.2713-2721

1996

Volltextzugriff (PDF)

Inflammatory breast cancer: a review

Journal of clinical oncology, 1992-06, Vol.10 (6), p.1014-1024

1992

Volltextzugriff (PDF)

Inflammatory breast cancer and body mass index

Journal of clinical oncology, 1998-12, Vol.16 (12), p.3731-3735

1998

Volltextzugriff (PDF)

1 – 25 von 648

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(586)
Mit Volltextzugriff
(551)

Publikationsform

Sprache

Englisch
(648)
Japanisch
(68)
Deutsch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(487)
Female
(437)
Science & Technology
(420)
Life Sciences & Biomedicine
(418)
Oncology
(355)
Breast Neoplasms - Drug Therapy
(335)
Middle Aged
(319)
Biological And Medical Sciences
(262)
Medical Sciences
(259)
Adult
(254)
Aged
(234)
Breast Neoplasms - Pathology
(179)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(152)
Chemotherapy
(150)
Pharmacology. Drug Treatments
(141)
Antineoplastic Agents
(130)
Tumors
(124)
Breast Cancer
(114)
Doxorubicin - Administration & Dosage
(102)
Cyclophosphamide - Administration & Dosage
(97)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Which threshold for ER positivity? a retrospective study based on 9639 patients

Role of biologic therapy and chemotherapy in hormone receptor- and HER2-positive breast cancer

Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer

Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer

Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511)

Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers

Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast Cancer

Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy

Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer

Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab

Collagen IV levels are elevated in the serum of patients with primary breast cancer compared to healthy volunteers

Locoregional Recurrence Patterns After Mastectomy and Doxorubicin-Based Chemotherapy: Implications for Postoperative Irradiation

Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer

Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer

Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy—results from the ACOSOG Z1041 (Alliance) trial

Management of Breast Cancer During Pregnancy Using a Standardized Protocol

Use of tamoxifen for breast cancer: twenty-eight years later

Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma

Inflammatory breast carcinoma incidence and survival : The Surveillance, Epidemiology, and end results program of the National Cancer Institute, 1975-1992

Update on endocrine therapy for breast cancer

Long-Term Results of Combined-Modality Therapy for Locally Advanced Breast Cancer With Ipsilateral Supraclavicular Metastases: The University of Texas M.D. Anderson Cancer Center Experience

Prospective Evaluation of Paclitaxel Versus Combination Chemotherapy With Fluorouracil, Doxorubicin, and Cyclophosphamide as Neoadjuvant Therapy in Patients With Operable Breast Cancer

Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast cancer

Inflammatory breast cancer: a review

Inflammatory breast cancer and body mass index

Suchergebnisse filtern